Skip to main content
. 2014 Feb 25;38(1):127–131. doi: 10.5535/arm.2014.38.1.127

Table 1.

Results of follow-up examinations of patients at before (pre) and 6 months after (post) BTA injection

graphic file with name arm-38-127-i001.jpg

BTA: botulinum toxin type A; MRC, Medical Research Council; NT, not testable.

a)Assessed in the MRC scale (0.5 points); grade 2 was divided to two subgrades: 2- (less than 50% of the active range of movement) and 2+ (more than 50% of the active range of movement).